Affordable Alternative: Glenmark Announces U.S. Launch of Micafungin for Injection USP
Mahwah, New Jersey, August 19, 2025 – Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
Advertisement
FDA Approves Precigen’s PAPZIMEOS, First Immunotherapy for Recurrent Respiratory Papillomatosis
August 19, 2025 — Germantown, MD – Precigen, Inc. (NASDAQ: PGEN) today announced that the U.S. Food and Drug...
Nike’s Phil and Penny Knight, $2B gift to Oregon Health & Science University’s Knight Cancer Institute
Portland, Oregon – August 14, 2025 – In what marks the largest single donation ever made to a U.S....
Eli Lilly $1.3B Collaboration with Boston based Superluminal to develop Small Molecule Therapy for Cardiometabolic and Obesity.
Boston, MA – August 14, 2025 – Superluminal Medicines, a pioneering drug discovery company integrating artificial intelligence, machine learning,...
Strand Therapeutics Secures $153M for mRNA Technology
By NewsDesk — Aug. 7, 2025 (America/New York) Strand Therapeutics, a Boston‑based startup pioneering programmable messenger RNA (mRNA) therapies, closed a $153 million Series B...
FDA Grants Accelerated Approval for EMRELIS™ (telisotuzumab) in Advanced NSCLC With High c-Met Overexpression
NORTH CHICAGO, Ill., May 14, 2025 — AbbVie (NYSE: ABBV) announced today that the U.S. Food and Drug Administration...
Advertisement
